Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Henney's candidacy for FDA commissioner

This article was originally published in The Gray Sheet

Executive Summary

Henney's candidacy for FDA commissioner: Return of Congress is logical time for the Clinton Administration to go public with the expected nomination of University of New Mexico VP-Health Sciences Jane Henney to be FDA commissioner. During the long Congressional recess, the administration had nothing to gain by nominating a candidate and giving any critics a free chance to build opposition. Albuquerque Journal picked up the possibility of Henney's return in a Jan. 21 article; other western dailies including L.A. Times are also running pre-appointment stories. Potential delays to the nomination include the protocol of waiting for nomination of the Surgeon General and distraction of the White House by the Lewinski scandal...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel